EAACI Congress 2025

13 - 16 June 2025 Glasgow, United Kingdom

Friday 13 Jun
Saturday 14 Jun
Sunday 15 Jun
Monday 16 Jun

Onsite
Synoptic

Scientific Industry

	Clyde Auditorium	Meeting Academy M2	Poster Zone	Lomond Auditorium	Hall 1	Innovation Hub	Meeting Academy M1	Forth	Boisdale	Alsh	Carron 1	Carron 2	Dochart 1	Dochart 2	EAACI Global Stage	Poster Area	E-TPS Display Only Digital section


7:00
30
8:00											MTE1 - Clinical studies on allergen immunotherapy with inhaled allergens: optimization and standardization of methodological approaches	MTE2 - Tips and tricks for biological treatment of CRSwNP: setting the indication, choosing the right biological, managing side effects, switching, tapering	MTE3 - MTE3	MTE4 - MTE4			e-TPS Display Only
30	SY1 - Clinical impact of Immune mechanisms driving asthma			SY2 - Cofactor-dependent food-induced anaphylaxis	IWS1 - Managing venom allergy: what’s new	IH1 - AI in allergy and lung health: predicting the future, transforming diagnosis	IWS2 - Management of delayed drug hypersensitivity reactions	IWS3 - Omics		JMA 1 - Inborn errors of immunity: Increasing awareness in clinical practice
9:00									SSS 1 - EAACI & JSA Joint Symposium : New Insights into the Mechanism and Treatment Strategies for Unified Airway Disease		L-OAS01 - Aerobiology and Pollution	L-OAS02 - Dermatology	L-FT01 - Allergen Immunotherapy	L-FT02 - Food Allergy
30
10:00
30	PL1 - Innovations and Emerging Therapies in Food Allergy: Bridging Research and Clinical Practice			PL2 - Infections and the Development of Allergy: Unraveling the Connections	PL3 - EAACI Highlight Plenary session Focus on Angioedema and Mast Cell Diseases
11:00
30
12:00		EAACI-COURSE - EAACI Course on immunology update : selected topics in basic and translational immunology	TPS20 - Pediatrics TPS22 - Microbiome TPS19 - Infections L-TPS06 - Immune deficiencies and autoimmunity 04 TPS16 - Immune deficiencies and autoimmunity 01 TPS23 - Genomics and proteomics + Ocular Allergy L-TPS04 - Food allergy 07 L-TPS03 - Food allergy 06 TPS10 - Food allergy 01 L-TPS05 - Drug allergy 06 TPS12 - Drug allergy 02 TPS11 - Drug allergy 01 TPS15 - Dermatology 01 TPS21 - COVID19 L-TPS07 - Biologicals 04 TPS18 - Biologicals 01 TPS17 - Basic immunology 01 L-TPS02 - Asthma 09 TPS07 - Asthma 02 TPS06 - Asthma 01 TPS14 - Anaphylaxis 02 TPS13 - Anaphylaxis 01 L-TPS08 - Allied health and primary care 02 L-TPS01 - Allergy diagnosis 14 TPS05 - Allergy diagnosis 05 TPS04 - Allergy diagnosis 04 TPS03 - Allergy diagnosis 03 TPS02 - Allergy diagnosis 02 TPS01 - Allergy diagnosis 01 TPS09 - Allergen immunotherapy 02 TPS08 - Allergen immunotherapy 01		Industry Session		SSS 2 - EAACI & APAPARI Joint Symposium : Emerging concepts in the management of food allergies				L-OAS03 - Clinical Immunology	L-OAS04 - Allergy Diagnosis	L-FT03 - Asthma	FT01 - Mastocytosis and mast cells diseases	POC - Codex Alimentarius & Precautionary Allergen Labelling (PAL): A New Era for Food Safety and Patient Information	TPS - Poster Session
30
13:00
30	SY3 - Beyond the future - perspectives in the diagnosis and treatment of allergy and asthma			SY4 - Management of severe food allergy in children	EAACI Special Session 1 - NAIS Forum 2025 : Updates in Anaphylaxis	ET 1 - EAACI Enlightening Talks-1	Industry Session	GBD 1 - Ground breaking discoveries 1	JMA 2 - Nano- and new technologies in diagnosing and treating allergies		OAS01 - Occupational Allergy: back to the future	OAS02 - Biologics in the combined airway	FT02 - Anaphylaxis, new perspectives and treatments	FT03 - Urticaria and Angioedema	P & C 1 - Is premedication useful to prevent non-IgE mediated immediate drug hypersensitivity reactions
14:00
30															P & C 2 - Timing in oral immunotherapy : Early vs. Late introduction
15:00	SY5 - Climate change effects on allergic patients: Emerging environmental threats			SY6 - Utility of molecular allergology in diagnosis and management of complex sensitization profiles	TSY1 - Bi-directional neuro-immune communications controlling allergy	OAS-CT1 - Clinical Trials on Airways Diseases	JMA3 - JMA IWS : Mastering the art of research: Writing, publishing, and building your research team	IWS4 - Assessment of control in chronic rhinitis and CRS	Industry Session		OAS03 - Allergic diseases in the perspective of innate immune responses	OAS04 - Drug Allergy: from bench to bedside	FT04 - Epidemiology and clinical management of drug allergy	FT05 - Immunotherapy from patient and epidemiological study perspective
30
16:00
30										Industry Session
17:00				SY7 - Treating chronic inflammation in the upper airways	SY8 - Diet and Allergy	IH2 - AI and Education: shaping the future of allergy and respiratory health	TSY2 - Aril-hydrocarbon receptor (AhR) : regulation and impact on human health	IWS5 - Exploring the clinical management of Eosinophilic Esophagitis			OAS05 - Hereditary Angioedema	OAS06 - From Basic Immunology to translational applications	FT06 - Mechanisms and applications in allergy and asthma research	FT07 - Biologicals, biomarkers and microbiome
30
18:00									Industry Session
30	Opening Ceremony
19:00
30
20:00

	Hall 1	Meeting Academy M1	Boisdale	Alsh


7:00
30
8:00
30
9:00
30
10:00
30
11:00
30
12:00	SAT01 - Astra Zeneca - Epithelial health: uniting the airway to transform patient care towards clinical remission
30
13:00
30		SAT06 - Stallergenes Greer - Breath of change: redefining respiratory allergy care with remission in sight
14:00
30
15:00			SAT08 - Menarini - The hidden Burden of Allergic Rhinitis: From Symptoms to Solutions for a better Quality of Life
30
16:00
30				SAT11 - Allergy Therapeutics - Subcutaneous allergen immunotherapy - we will rock you
17:00
30
18:00			MSAT 1 - Myth Busting in Peanut Allergy: Separating Fact from Fiction
30
19:00
30
20:00

Scientific Industry

	Clyde Auditorium	Poster Zone	Lomond Auditorium	Hall 1	Innovation Hub	Meeting Academy M1	Forth	Boisdale	Alsh	Carron 1	Carron 2	Dochart 1	Dochart 2	EAACI Global Stage	Poster Area


7:00
30
8:00										MTE5 - Allergen immunotherapy for allergic disease: Indications and contraindications	MTE6 - Pathogenic mechanisms in the evolution of food allergy	MTE7 - Diversity of regulatory B cells: Markers and functions	MTE8 - Clinical Pathway on direct drug provocation testing
30	SY9 - Impact of natural disasters on respiratory and immune health			SY10 - Chronic spontaneous urticaria: latest clinical developments	IH3 - Nanotechnology in allergy: From diagnostics to precision therapies	IWS6 - Innovations in Betalactam allergy diagnosis			JMA4 - Year in review
9:00								Industry Session		L-OAS05 - Asthma: from bench to bedside	L-OAS06 - Basic Immunology	L-FT04 - Food Allergy from Diagnosis to Management	L-FT05 - Allergy Diagnosis
30
10:00
30	PL4 - Drug Allergy: Advances in Diagnosis, Management, and Prevention		PL5 - Microbiota and Immune Regulation: Insights from Gut to Lungs Across the Lifespan	PL6 - Highlights of EAACI Guidelines: Latest Developments and Clinical Applications
11:00
30
12:00		TPS47 - Occupational allergy TPS49 - Immunomodulation and nutrition + System medicine TPS40 - Immune deficiencies and autoimmunity 02 TPS35 - Food allergy 03 TPS34 - Food allergy 02 TPS46 - Epidemiology TPS44 - Environmental allergy and climate change + One health TPS43 - ENT L-TPS12 - Drug allergy 07 TPS36 - Drug allergy 03 TPS39 - Dermatology 03 TPS38 - Dermatology 02 TPS42 - Biologicals 02 TPS41 - Basic immunology 02 L-TPS10 - Asthma 10 TPS31 - Asthma 05 TPS30 - Asthma 04 TPS29 - Asthma 03 L-TPS13 - Anaphylaxis 05 TPS37 - Anaphylaxis 03 L-TPS09 - Allergy diagnosis 15 TPS28 - Allergy diagnosis 09 TPS27 - Allergy diagnosis 08 TPS26 - Allergy diagnosis 07 TPS25 - Allergy diagnosis 06 TPS48 - AllergoOncology L-TPS11 - Allergen immunotherapy 06 TPS33 - Allergen immunotherapy 04 TPS32 - Allergen immunotherapy 03 TPS45 - Aerobiology and pollution	Industry Session	SSS 3 - EAACI & SLAAI Joint Symposium : Air pollution In Latin America		Industry Session			Industry Session	L-OAS07 - Oral immunotherapy for Food Allergy	L-OAS08 - Pediatrics	L-FT06 - Clinical Immunology	L-FT07 - ENT		TPS - Poster Session
30
13:00
30	SY11 - T2 inflammation in the upper airways: from bench to bedside		SY12 - Food allergy: from prevention to prediction of therapeutic responses	TSY3 - Autoimmunity in allergic diseases: implications for treatment			SY13 - Therapeutic options in indolent systemic mastocytosis: a roadmap	SSS 4 - EAACI & ACAAI Joint Symposium : Unified Airway Disease		OAS07 - Insights in pediatric allergy: from bench to bedside	OAS08 - Phenotypes and mechanisms in asthmatic diseases	FT08 - Biological treatment in asthmatic diseases	FT09 - Allergen immunotherapy in clinical studies	P & C 3 - Is remission an adequate therapeutic goal for severe asthma
14:00					ET 2 - EAACI Enlightening Talks - 2				Industry Session
30														P & C 4 - Should dupilumab be the standard first treatment choice for severe atopic dermatitis?
15:00	SY14 - Sustainable diets the gut microbiome and the immune		SY15 - Airway immune metabolism in allergic diseases	TSY4 - Climate Change and Insect allergy	OAS-CT2 - Clinical Trials on Dermatology		SSS 5 - EAACI & AAAAI Joint Symposium – Atopic Dermatitis 2025: Novel Pathophysiology & Treatment Insights			OAS09 - Progress in understanding the mechanisms of airborne allergen immunotherapy	OAS10 - Understanding of mechanisms of food immunotherapy	FT10 - Skin and allergy	FT11 - Biologics and airway disease in pediatric care
30								Industry Session
16:00
30
17:00	SY16 - Healthier planet, healthier people: the recipe for a sustainable future		SY17 - Non-allergic comorbidities in allergic patients	SY18 - Th2 immune responses and clinical outcomes	IH4 - Artificial intelligence in allergy and health: from analytics to patient interaction	IWS8 - Interpreting clinical and laboratory signs of mastocytosis				OAS11 - Clinical and immunological aspects in allergen immunotherapy	OAS12 - New trends in atopic dermatitis	FT12 - Early-life influences on allergy and immune development	FT13 - Basic research in food allergy	YIR - YIR 1
30								Industry Session	Industry Session
18:00
30
19:00

	Lomond Auditorium	Meeting Academy M1	Boisdale	Alsh


7:00
30
8:00
30
9:00			SAT12 - Celldex - Shining a Light on Mast Cells in Chronic Spontaneous Urticaria
30
10:00
30
11:00
30
12:00	SAT13 - ALK - The evolution of immunotherapy in children – from respiratory to peanut allergy	SAT14 - CSL Behring - Changing the Flow: Shifting Hereditary Angioedema Treatment Toward Normalization of Patients’ Lives		SAT17 - Blueprint - Unmasking Indolent Systemic Mastocytosis: Strategies for Accurate Diagnosis & Comprehensive Care to Improve Patient Outcomes
30
13:00
30
14:00				SAT19 - HAL Allergy - From stings to sneezes: to be or not to bee
30
15:00
30			SAT20 - Thermo Fisher Scientific - Utility of allergen specific IgE testing in daily routine: why, who, when and how?
16:00
30
17:00
30			SAT22 - Siemens Healthineers - Unlocking Molecular Diagnostics: From Basics to Clinical Impact	SAT23 - KalVista - Closing Gaps in HAE Management: Understanding what control means for your HAE patients
18:00
30
19:00

Scientific Industry

	Clyde Auditorium	Poster Zone	Lomond Auditorium	Hall 1	Innovation Hub	Meeting Academy M1	Forth	Boisdale	Alsh	Carron 1	Carron 2	Dochart 1	Dochart 2	EAACI Global Stage


7:00
30
8:00										MTE 9 - Management of the reactions to inodiated contrast media	MTE 10 - Mast cell activation test and food allergy	MTE11 - Improve statistics to analyse your data	MTE12 - Recent advances in natural killer cells and innate lymphoid cells
30
9:00	SY19 - Atopic dermatitis; the other side of the mirror		SY20 - Present and future of allergen immunotherapy	SY21 - Very early nutrition and allergy outcomes	IH5 - Telemedicine	IWS9 - How to manage asthma patients in the clinic	IWS10 - Management of hypersensitivity to chemotherapy	SSS 6 - EAACI & KAAACI Joint Symposium : New horizons toward controlling allergy and allergens	TSY 5 - The role of mucus in asthma and CRS severity	OAS13 - Diagnosis and management of Eosinophilic Esophagitis	OAS14 - Natural history and treatment of food allergy	FT14 - Allied health and primary care	FT15 - The Heterogenicity of asthma	JMA5 - JM-NAS Symposium : Early life exposure and allergy development
30
10:00
30
11:00	PL7 - New horizons in the management of severe atopic dermatitis		PL8 - One Health: Addressing Environmental Challenges in Allergy and Immunology	PL9 - Highlights of EAACI Task Forces: Bridging Innovation and Clinical Practice
30
12:00
30
13:00		TPS70 - Eosinophilic esophagitis TPS62 - Drug allergy 05 TPS61 - Drug allergy 04 L-TPS20 - Dermatology 05 TPS64 - Dermatology 04 TPS68 - Biomarkers TPS67 - Biologicals 03 L-TPS21 - Basic immunology 04 TPS66 - Basic immunology 03 L-TPS16 - Asthma 11 TPS57 - Asthma 08 TPS56 - Asthma 07 TPS55 - Asthma 06 TPS73 - Artificial Intelligence + Epithelial cell biology L-TPS19 - Anaphylaxis 06 TPS63 - Anaphylaxis 04 TPS69 - Allied health and primary care L-TPS15 - Allergy diagnosis 17 L-TPS14 - Allergy diagnosis 16 TPS54 - Allergy diagnosis 13 TPS53 - Allergy diagnosis 12 TPS52 - Allergy diagnosis 11 TPS51 - Allergy diagnosis 10 L-TPS18 - Allergen immunotherapy 08 L-TPS17 - Allergen immunotherapy 07 TPS58 - Allergen immunotherapy 05		SSS 7 - EAACI & APAAACI Joint Symposium : Recent Developments in Environmental Issues, Allergic Diseases, and Vaccination in Asia Pacific	PiS01 - A booster for our (interconnected) future				Industry Session	L-OAS09 - Food Allergy	L-OAS10 - Drug Allergy	L-FT08 - Dermatology	L-FT09 - Anaphylaxis
30
14:00
30
15:00
30
16:00
30
17:00
30
18:00
30
19:00

	Boisdale	Alsh


7:00
30
8:00
30
9:00
30
10:00
30
11:00
30
12:00
30
13:00
30
14:00
30
15:00
30
16:00
30
17:00
30
18:00
30
19:00

Scientific

	Clyde Auditorium	Lomond Auditorium	Hall 1	Meeting Academy M1	Forth	Boisdale	Alsh	Carron 1	Carron 2	Dochart 1	Dochart 2


9:00
30
10:00
30
11:00
30
12:00
30
13:00
30
14:00
30
15:00

Last updated
14.04.2025, 09:33

EAACI Congress 2025

Share this pen